During the past decade, Twin Cities Clinical Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Twin Cities Clinical Research" #1 sponsor was "Novartis" with 2 trials, followed by "Orexigen Therapeutics, Inc" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "AstraZeneca" with 1 trials sponsored and "Dynavax Technologies Corporation" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Twin Cities Clinical Research" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Twin Cities Clinical Research" are "Chronic Renal Insufficiency" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Hypertension" (2 trials), "Obesity" (2 trials) and "Overweight" (2 trials). Many other conditions were trialed in "Twin Cities Clinical Research" in a lesser frequency.

Most popular intervention types in "Twin Cities Clinical Research" are "Drug" (10 trials), "Behavioral" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ancillary therapy" (2 trials), "1018 ISS immunostimulatory oligonucleotide with HBV surface antigen" (1 trials), "CTAP101 Capsules" (1 trials) and "CTAP101 Injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Twin Cities Clinical Research" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Twin Cities Clinical Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Twin Cities Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Twin Cities Clinical Research, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".